Position in TEVA
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$32,219
-$11,605 QoQ
Shares Held
951
-34.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.03%
of 13F equity value
Holder Rank
#546
of 671 holders
Holding Since
Dec 2024
4 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Bayforest Capital Ltd holds $1,146,366 across 9 Drug Manufacturers - Specialty & Generic names. TEVA ranks #5 (2.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRGO |
PERRIGO Co plc
|
39,667 | $412,140 | |
| 2 | BCRX |
Biocryst Pharmaceuticals Inc
|
27,728 | $277,280 | |
| 3 | VTRS |
Viatris Inc
|
17,424 | $276,693 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
4,453 | $71,381 | |
| 5 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
951 | $32,219 | |
| 6 | NBIX |
Neurocrine Biosciences Inc
|
140 | $23,595 | |
| 7 | ANIP |
Ani Pharmaceuticals Inc
|
270 | $22,350 | |
| 8 | ELAN |
Elanco Animal Health Inc
|
755 | $18,580 |
All Filings in TEVA
Export CSV
4 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $32,219 | 951 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $43,824 | 1,455 | Shares | Sole | 2026-04-15 | |
| 2025-03-31 | $57,222 | 3,723 | Shares | Sole | 2025-05-19 | |
| 2024-12-31 | $167,459 | 7,598 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||